ARTICLE | Clinical News
Interleukin-1 regulatory update
November 6, 2000 8:00 AM UTC
ILGN received U.S. Patent No. 6,140,047 covering IL-1 gene variations (single nucleotide polymorphisms (SNPs)) that increase arterial inflammation and confer increased risk of clinically significant h...